Tevogen Bio Holdings Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,598 | -15,871 | -10,367 | -13,727 | -4,283 |
| Depreciation Amortization | 423 | 396 | 105 | 404 | 300 |
| Accounts payable and accrued liabilities | -1,992 | -960 | -536 | 1,686 | 2,324 |
| Other Working Capital | -2,692 | -1,563 | -350 | -6 | 744 |
| Other Operating Activity | 15,712 | 11,499 | 7,839 | -355 | -8,036 |
| Operating Cash Flow | $-10,147 | $-6,498 | $-3,308 | $-11,999 | $-8,951 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,400 | 3,400 | 2,000 | 1,000 | 1,000 |
| Common Stock Issued | 3,101 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 3,400 | 2,500 | 2,000 | 11,229 | 9,229 |
| Financing Cash Flow | $9,901 | $5,900 | $4,000 | $12,229 | $10,229 |
| Beginning Cash Position | 1,283 | 1,283 | 1,283 | 1,052 | 1,052 |
| End Cash Position | 1,037 | 685 | 1,975 | 1,283 | 2,331 |
| Net Cash Flow | $-246 | $-598 | $692 | $231 | $1,278 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,147 | -6,498 | -3,308 | -11,999 | -8,951 |
| Free Cash Flow | -10,147 | -6,498 | -3,308 | -11,999 | -8,951 |